Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MAP3K8 encodes a serine/threonine-specific protein kinase involved in the regulation of inflammatory and immune responses. It activates ERK1/2, p38 MAP kinases, and IκB kinases, leading to NF-κB activation and the production of pro-inflammatory cytokines. It has been implicated in cancer development and chronic inflammatory diseases. Pharmacological inhibition is being explored for treatment of chronic inflammation.
Inhibition of MAP3K8 activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitogen-Activated Protein Kinase Kinase Kinase 8 (MAP3K8).